Cabazitaxel-loaded redox-responsive nanocarrier based on d-alpha-tocopheryl-chitosan and hyaluronic acid for improved anti-tumor efficacy in DMBA-induced breast cancer model
Open Access
- 13 September 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 5 (19) , 7789-7808
Abstract
The study involved the formulation of cabazitaxel loaded D-alpha-tocopheryl succinate/chitosan conjugate (CSVE) and hyaluronic acid (HA) based redox-responsive nanoparticles crosslinked using 3,3′-dithiodipropionic acid (DTPA). The nanoparticle surface was functionalized with cetuximab (Cmab) to give CSVE/HA/DTPA/Cmab NP for EGFR targeted delivery of the payload. The formulations were subjected to particle analysis, morphological assessment, solid-state characterization, and in vitro drug release studies. The results showed cationic, sub-200 nm sized spherical particles with the glutathione-responsive release of cabazitaxel. In vitro studies revealed a marked decrease in the IC50 value, improved cellular uptake, and a superior apoptotic effect. To determine the in vivo efficacy of the formulation, pharmacokinetic assessment, tumor regression analysis, and survival analysis were performed. The nanoparticles showed improved pharmacokinetic and anti-tumor efficacy compared to free cabazitaxel. The prepared nanoparticles demonstrated immense potential in targeted delivery of the payload for enhanced breast cancer therapy.Keywords
Funding Information
- Banaras Hindu University (R/Dev/D/IoE/Incentive/2021-22/32449)
This publication has 81 references indexed in Scilit:
- Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer ImmunotherapySmall, 2023
- A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cellsCarbohydrate Polymers, 2021
- LHRH‐Targeted Redox‐Responsive Crosslinked Micelles Impart Selective Drug Delivery and Effective Chemotherapy in Triple‐Negative Breast CancerAdvanced Healthcare Materials, 2020
- Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapyBiomaterials, 2020
- Novel Redox‐Responsive Polymeric Magnetosomes with Tunable Magnetic Resonance Property for In Vivo Drug Release Visualization and Dual‐Modal Cancer TherapyAdvanced Functional Materials, 2018
- Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapyBiomaterials, 2017
- Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cellsMolecular and Cellular Biochemistry, 2016
- Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cellsBiomaterials, 2015
- Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acidActa Biomaterialia, 2015
- Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cellsCarbohydrate Polymers, 2013